Development of a new surgical technique to infuse kynurenic acid to optic nerves in chickens for studying loss of myelination.
CNS, central nervous system
Chicken
GFAP, glial fibrillary acidic protein
Infusion
KYNA, kynurenic acid
Kynurenic acid
MAG, myelin associated glycoprotein
MBP, myelin basic protein
Myelin
NC, negative control
ON, optic nerve
Optic nerve
PBS, phosphate buffered saline
PLP, proteolipid protein
Subdural
Journal
Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
received:
26
07
2022
revised:
14
02
2023
accepted:
01
03
2023
entrez:
20
3
2023
pubmed:
21
3
2023
medline:
21
3
2023
Statut:
epublish
Résumé
Prolonged infusion of a high dose of kynurenic acid (KYNA) reduces the myelin content in the rat spinal cord with preservation of the axonal integrity and without inducing an inflammatory response. We hypothesized that subdural infusion of a high concentration of KYNA can induce myelin loss in the optic nerves (ONs) of chickens. However, existing methods to deliver agents to the ON are inefficient, unlocalized and provide only acute exposure. Thus, we developed a surgical approach for sustained delivery of KYNA to the chicken ON. In brief, the novel surgical technique, which does not include excision of the extraocular muscles, involves incision of the skin and underlying fascial sheath to access the optic nerve within the muscle cone, implantation of a catheter in the dura of the optic nerve, the other end of which exits the orbit under the skin. The catheter runs under the skin near the lateral canthus, over the ears to the back of the neck, where a second incision is made to both implant the osmotic pump and to attach the catheter to the osmotic pump. India ink was used to confirm prolonged sustained administration to the optic nerves and across the chiasm. This surgical model was used to investigate KYNA's effect(s) on myelin loss in the ON. ONs of 7-day old chickens were infused with 50 mM KYNA or phosphate buffered saline (PBS) for seven days. Analysis of KYNA-infused contralateral ON g-ratios and protein levels indicated a reduction in myelin. These findings demonstrate the utility of our surgical approach for sustained delivery of KYNA into the ON and suggest a role for KYNA in modulating CNS myelination.
Identifiants
pubmed: 36938412
doi: 10.1016/j.heliyon.2023.e14361
pii: S2405-8440(23)01568-2
pmc: PMC10020079
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e14361Informations de copyright
© 2023 Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8830-5
pubmed: 9238063
Int J Tryptophan Res. 2013 Sep 04;6:47-55
pubmed: 24049450
Curr Opin Neurobiol. 2014 Aug;27:31-8
pubmed: 24608164
J Neurosci. 2010 Jun 30;30(26):8953-64
pubmed: 20592216
Int J Biochem Cell Biol. 2002 Mar;34(3):211-5
pubmed: 11849988
J Neurosci. 2001 Oct 1;21(19):7463-73
pubmed: 11567036
Adv Clin Exp Med. 2021 Aug;30(8):775-778
pubmed: 34418336
Invest Ophthalmol Vis Sci. 2005 Oct;46(10):3800-6
pubmed: 16186366
Neurology. 1992 Sep;42(9):1702-6
pubmed: 1513457
Exp Ther Med. 2011 Nov;2(6):1183-1185
pubmed: 22977641
Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):7990-4
pubmed: 8367453
J Neurotrauma. 2008 Mar;25(3):196-204
pubmed: 18352833
Glia. 1991;4(2):233-43
pubmed: 1827781
Glia. 2013 Aug;61(8):1218-35
pubmed: 23650091
J Pharm Sci. 2010 May;99(5):2219-39
pubmed: 19894268
PLoS One. 2009 Nov 13;4(11):e7754
pubmed: 19915661
Curr Eye Res. 2007 Jan;32(1):27-32
pubmed: 17364732
Brain Res. 1991 Mar 1;542(2):307-12
pubmed: 2029638
Open Ophthalmol J. 2008 May 09;2:94-101
pubmed: 19516911
Nat Rev Neurosci. 2003 Sep;4(9):703-13
pubmed: 12951563
Brain Res. 1994 Apr 11;642(1-2):259-66
pubmed: 8032887
Graefes Arch Clin Exp Ophthalmol. 2002 Aug;240(8):687-91
pubmed: 12192464
Neurochem Res. 2015 Feb;40(2):362-71
pubmed: 25503479
J Neural Transm (Vienna). 1999;106(2):165-81
pubmed: 10226937
J Neural Transm Suppl. 2006;(70):285-304
pubmed: 17017544
Forensic Sci Int. 1987 Sep;35(1):1-10
pubmed: 3315904
Folia Neuropathol. 2013;51(3):189-202
pubmed: 24114636
PLoS One. 2015 Nov 12;10(11):e0142598
pubmed: 26562835
Eur J Pharmacol. 1999 Jun 30;375(1-3):87-100
pubmed: 10443567
J Neuroinflammation. 2012 May 14;9:92
pubmed: 22583833
Toxicol Sci. 2010 May;115(1):89-97
pubmed: 20106948
Cell Rep Methods. 2021 Dec 20;1(8):
pubmed: 35128514
Vision Res. 2003 Mar;43(5):497-503
pubmed: 12594996
Brain Res. 1982 Sep 9;247(1):184-7
pubmed: 6215086
Neuroscience. 2004;123(2):441-9
pubmed: 14698751
Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6431-40
pubmed: 20688743
Glia. 1996 May;17(1):52-62
pubmed: 8723842
J Neurol Sci. 1973 Sep;20(1):73-83
pubmed: 4744512
Schizophr Res. 2005 Dec 15;80(2-3):315-22
pubmed: 16125901
Neuroscience. 2016 Mar 24;318:178-89
pubmed: 26804242